When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BBIO - Eidos Therapeutics downgraded by Citi analyst
BridgeBio Pharma Inc.
Eidos Therapeutics ([[EIDX]] +3.3%) downgraded to neutral by Citi analyst Joel Baetty, and the PT revised to $73.26, down from $80.The analyst believes BridgeBio's (BBIO) offer to acquire the remaining outstanding shares of Eidos for $73.26 per share is 'fairly likely to materialize.'Also, he finds its unlikely for any other party to submit a more competitive offer.Wall St. analysts give the stock a Neutral rating and target of $61.97.Source